This year’s American Society for Hematology (ASH) Annual Meeting final programme and abstracts are now available to view. Over 400 clinical and non-clinical abstracts specifically related to myeloma are being presented at the meeting being held on 9 – 12 December 2017 in Atlanta, USA. Highlights include:

  • The latest results from the Myeloma XI trial (Abstracts 436, 1854 and 3040)
  • The first analysis from the Phase II MUK five trial (Abstract 835)
  • The interim results from the MUK seven trial (Abstract 1851)
  • The latest research in chimeric antigen receptor T cell (CAR-T cell) therapy (Abstracts 506, 740, 742 and 3142)

View all abstracts